Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition

• Published in: Toxicology and applied pharmacology Vol. 401; p. 115110
• Main Authors: Wang, Meng, Li, Shanshan, Wang, Youlin, Cheng, Hui, Su, Jingjing, Li, Qinglin
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 15-08-2020
• Subjects: Epithelial-to-mesenchymal transition; Ferroptosis; Gambogenic acid; Melanoma; Ferroptosis; Epithelial-to-mesenchymal transition; Gambogenic acid; Melanoma
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2020.115110

Melanoma is characterized by high malignancy and early onset of metastasis. Epithelial-to-mesenchymal transition (EMT) is an early event during tumor metastasis. Tumor cells that develop EMT can escape apoptosis, but they are vulnerable to ferroptosis inducers. Gambogenic acid (GNA), a xanthone found in Gamboge, has cytotoxic effects in highly invasive melanoma cells. This study investigated the anti-melanoma effect and mechanism of action of GNA in TGF-β1-induced EMT melanoma cells. We found that GNA significantly inhibited the invasion, migration and EMT in melanoma cells, and these cells exhibited small mitochondrial wrinkling (an important feature of ferroptosis). An iron chelator, but not an apoptosis inhibitor or a necrosis inhibitor, abolished the inhibitory effects of GNA on proliferation, invasion and migration of TGF-β1-stimulated melanoma cells. GNA upregulated the expression of p53, solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) in the model cells, contributing to the mechanisms underlying GNA-induced ferroptosis. Collectively, our findings suggest that GNA induces ferroptosis in TGF-β1-stimulated melanoma cells via the p53/SLC7A11/GPX4 signaling pathway.
•Gambogenic acid inhibits invasion, migration, and EMT in TGF-β1-stimulated melanoma cells.•Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.•Gambogenic acid triggers ferroptosis in TGF-β1-treated melanoma cells by activating p53/SLC7A11/GPX4.